{"transactions":[{"id":4637321,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Ordinary Shares","published_at":"2026-10-07T21:44:28.000Z","date":"2026-10-06","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":236.4,"value":472800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a plan adopted by the reporting person on June 4, 2026 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."}],"balance_after":141394,"source":{"system":"sec-edgar","filing":"0001607737-26-000016","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607737/000160773726000016/edgardoc.xml","form_type":"4"}},{"id":4614763,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Ordinary Shares","published_at":"2026-09-10T20:33:02.000Z","date":"2026-09-08","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":243.03,"value":486060.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a plan adopted by the reporting person on June 4, 2026 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."}],"balance_after":143394,"source":{"system":"sec-edgar","filing":"0001607737-26-000013","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1607737/000160773726000013/edgardoc.xml","form_type":"4"}},{"id":4614762,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Ordinary Shares","published_at":"2026-09-10T20:33:02.000Z","date":"2026-09-08","kind":"tax_withholding","planned":true,"acquired":false,"shares":1967,"price":246.81,"value":485475.27,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":145394,"source":{"system":"sec-edgar","filing":"0001607737-26-000013","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607737/000160773726000013/edgardoc.xml","form_type":"4"}},{"id":717581,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Ordinary Shares","published_at":"2026-07-02T22:21:34.000Z","date":"2026-06-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":4835,"price":237.72,"value":1149376.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":147361,"source":{"system":"sec-edgar","filing":"0001607737-26-000011","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000160773726000011/edgardoc.xml","form_type":"4"}},{"id":747709,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Ordinary Shares","published_at":"2026-06-05T20:40:45.000Z","date":"2026-06-03","kind":"gift","planned":false,"acquired":false,"shares":600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were donated to The Gala Family Fund, a donor-advised fund."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person acquired 166 ordinary shares under a Section 423 Employee Stock Purchase Plan on May 29, 2026."}],"balance_after":152196,"source":{"system":"sec-edgar","filing":"0001607737-26-000008","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000160773726000008/edgardoc.xml","form_type":"4"}},{"id":757754,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-01T21:34:19.000Z","date":"2026-05-28","kind":"grant","planned":false,"acquired":true,"shares":5605,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The RSU Award was granted on May 28, 2026 and 100% of the RSU Award will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2027 Annual Meeting of Stockholders. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 9,418 unvested restricted stock units, 5,605 of which were granted on May 28, 2026 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2027 Annual Meeting of Stockholders, and 3,813 of which were granted on March 6, 2025 and shall vest through March 6, 2028."}],"balance_after":12486,"source":{"system":"sec-edgar","filing":"0001093557-26-000116","document":"wk-form4_1780349656.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355726000116/wk-form4_1780349656.xml","form_type":"4"}},{"id":853298,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Ordinary Shares","published_at":"2026-03-09T21:10:12.000Z","date":"2026-03-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":7065,"price":188.69,"value":1333094.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":152630,"source":{"system":"sec-edgar","filing":"0001607737-26-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000160773726000006/edgardoc.xml","form_type":"4"}},{"id":873788,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Ordinary Shares","published_at":"2026-03-02T22:12:10.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":44465,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2026, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years."}],"balance_after":159695,"source":{"system":"sec-edgar","filing":"0001607737-26-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000160773726000004/edgardoc.xml","form_type":"4"}},{"id":934104,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Ordinary Shares","published_at":"2026-01-22T00:49:49.000Z","date":"2026-01-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":5371,"price":171.16,"value":919300.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares withheld from the vesting and distribution of performance share awards to satisfy the reporting person's tax obligations."}],"balance_after":115230,"source":{"system":"sec-edgar","filing":"0001607737-26-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000160773726000002/edgardoc.xml","form_type":"4"}},{"id":934103,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Ordinary Shares","published_at":"2026-01-22T00:49:49.000Z","date":"2026-01-16","kind":"grant","planned":false,"acquired":true,"shares":12741,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents ordinary shares of the Issuer delivered pursuant to the terms of performance share awards made to the reporting person on March 3, 2023. The performance-based vesting requirements applicable to such awards were satisfied on January 16, 2026, which represents the date on which the level of performance\nattained was certified."}],"balance_after":120601,"source":{"system":"sec-edgar","filing":"0001607737-26-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000160773726000002/edgardoc.xml","form_type":"4"}},{"id":975786,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Ordinary Shares","published_at":"2025-12-09T23:24:08.000Z","date":"2025-12-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":80,"price":166.91,"value":13352.8,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Reporting Person acquired 71 ordinary shares under a Section 423 Employee Stock Purchase Plan on November 28, 2025."}],"balance_after":107860,"source":{"system":"sec-edgar","filing":"0001607737-25-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000160773725000004/edgardoc.xml","form_type":"4"}},{"id":1069954,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:31:19.000Z","date":"2025-08-07","kind":"grant","planned":false,"acquired":true,"shares":18808,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of September, 2025, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person acquired 166 ordinary shares under a Section 423 Employee Stock Purchase Plan on May 30, 2025."}],"balance_after":107869,"source":{"system":"sec-edgar","filing":"0001765581-25-000074","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558125000074/edgardoc.xml","form_type":"4"}},{"id":1091486,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-07T20:15:09.000Z","date":"2025-05-08","kind":"grant","planned":false,"acquired":true,"shares":1161,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The original Form 4, filed on May 12, 2025, is being amended by this Form 4 to correct a calculation error that misreported the number of unvested restricted stock units granted to the reporting person on May 8, 2025. This amendment correctly reports the number of unvested restricted stock units granted to the reporting person on May 8, 2025."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents unvested restricted stock units which were granted on May 8, 2025 and shall vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2026 Annual Meeting of Stockholders."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Included in this number are 6,881 unvested restricted stock units, 5,720 of which were granted on March 6, 2025 and shall vest through March 6, 2028 and 1,161 of which were granted on May 8,  2025 and shall vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2026 Annual Meeting of Stockholders."}],"balance_after":6881,"source":{"system":"sec-edgar","filing":"0001093557-25-000224","document":"wk-form4a_1751919300.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355725000224/wk-form4a_1751919300.xml","form_type":"4/A","original_submission_date":"2025-05-12"}},{"id":1152749,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-12T20:09:05.000Z","date":"2025-05-08","kind":"grant","planned":false,"acquired":true,"shares":5074,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The RSU Award was granted on May 8, 2025 and 100% of the RSU Award will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2026 Annual Meeting of Stockholders. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 10,794 unvested restricted stock units, 5,720 of which were granted on March 6, 2025 and shall vest through March 6, 2028 and 5,074 of which were granted on May 8,  2025 and shall vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2026 Annual Meeting of Stockholders."}],"balance_after":10794,"source":{"system":"sec-edgar","filing":"0001093557-25-000154","document":"wk-form4_1747080539.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355725000154/wk-form4_1747080539.xml","form_type":"4"}},{"id":1215837,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-10T21:01:54.000Z","date":"2025-03-06","kind":"grant","planned":false,"acquired":true,"shares":5720,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units that are exempt from Section 16b-3 and are subject to vesting in three equal annual installments from the date of grant. Restricted stock units represent a contingent right to receive one share of DexCom, Inc. Common Stock."}],"balance_after":5720,"source":{"system":"sec-edgar","filing":"0001093557-25-000055","document":"wk-form4_1741640507.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355725000055/wk-form4_1741640507.xml","form_type":"4"}},{"id":1217097,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Ordinary Shares","published_at":"2025-03-07T23:45:46.000Z","date":"2025-03-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5704,"price":138.95,"value":792570.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":88895,"source":{"system":"sec-edgar","filing":"0001765581-25-000025","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558125000025/edgardoc.xml","form_type":"4"}},{"id":1235493,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Ordinary Shares","published_at":"2025-03-04T00:29:14.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":11555,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units will vest in full on June 30, 2026."}],"balance_after":94599,"source":{"system":"sec-edgar","filing":"0001765581-25-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558125000014/edgardoc.xml","form_type":"4"}},{"id":1235492,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Ordinary Shares","published_at":"2025-03-04T00:29:14.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":23111,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2025, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years."}],"balance_after":83044,"source":{"system":"sec-edgar","filing":"0001765581-25-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558125000014/edgardoc.xml","form_type":"4"}},{"id":1297362,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Ordinary Shares","published_at":"2025-01-22T23:50:45.000Z","date":"2025-01-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":3300,"price":122.62,"value":404646.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares to be withheld from the vesting and distribution of performance award shares to satisfy the reporting person's tax obligations."}],"balance_after":59933,"source":{"system":"sec-edgar","filing":"0001805688-25-000009","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000180568825000009/edgardoc.xml","form_type":"4"}},{"id":1297361,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Ordinary Shares","published_at":"2025-01-22T23:50:45.000Z","date":"2025-01-17","kind":"grant","planned":false,"acquired":true,"shares":7741,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents ordinary shares of Jazz Pharamceuticals that will be delivered pursuant to the terms of performance share awards made to the reporting person on March 3, 2022. The performance-based vesting requirements applicable to such awards were satisfied on January 17, 2025, which represents the date on which the level of performance attained was certified."}],"balance_after":63233,"source":{"system":"sec-edgar","filing":"0001805688-25-000009","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000180568825000009/edgardoc.xml","form_type":"4"}},{"id":1338815,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Ordinary Shares","published_at":"2024-12-09T23:45:09.000Z","date":"2024-12-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":80,"price":123.45,"value":9876.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person acquired 167 ordinary shares on May 31, 2024 and 48 ordinary shares on November 29, 2024 under a Section 423 Employee Stock Purchase Plan."}],"balance_after":55492,"source":{"system":"sec-edgar","filing":"0001765581-24-000094","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558124000094/edgardoc.xml","form_type":"4"}},{"id":1544404,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Ordinary Shares","published_at":"2024-04-09T20:39:33.000Z","date":"2024-04-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":1736,"price":115.21,"value":200004.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":55357,"source":{"system":"sec-edgar","filing":"0001765581-24-000040","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558124000040/edgardoc.xml","form_type":"4"}},{"id":1588893,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Ordinary Shares","published_at":"2024-03-08T02:53:55.000Z","date":"2024-03-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":3622,"price":117.53,"value":425693.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":57093,"source":{"system":"sec-edgar","filing":"0001765581-24-000036","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558124000036/edgardoc.xml","form_type":"4"}},{"id":1595011,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Ordinary Shares","published_at":"2024-03-06T00:44:21.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":19916,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2024, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years."}],"balance_after":60715,"source":{"system":"sec-edgar","filing":"0001765581-24-000015","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558124000015/edgardoc.xml","form_type":"4"}},{"id":1675061,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Ordinary Shares","published_at":"2024-01-19T23:23:54.000Z","date":"2024-01-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":3204,"price":119.13,"value":381692.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Shares to be withheld from the vesting and distribution of performance award shares to satisfy the reporting person's tax obligations."}],"balance_after":40799,"source":{"system":"sec-edgar","filing":"0001784606-24-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000178460624000006/edgardoc.xml","form_type":"4"}},{"id":1675060,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Ordinary Shares","published_at":"2024-01-19T23:23:54.000Z","date":"2024-01-17","kind":"grant","planned":false,"acquired":true,"shares":7079,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents ordinary shares of Jazz Pharamceuticals that will be delivered pursuant to the terms of performance share awards made to the reporting person on May 5, 2021. The performance-based vesting requirements applicable to such awards were satisfied on January 17, 2024, which represents the date on which the level of performance attained was certified."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person acquired 37 ordinary shares under a Section 423 Employee Stock Purchase Plan on November 30, 2023."}],"balance_after":44003,"source":{"system":"sec-edgar","filing":"0001784606-24-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000178460624000006/edgardoc.xml","form_type":"4"}},{"id":1742079,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Ordinary Shares","published_at":"2023-11-14T22:50:23.000Z","date":"2023-11-10","kind":"grant","planned":false,"acquired":true,"shares":772,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of December 5, 2023, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 137 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 31, 2023."}],"balance_after":36887,"source":{"system":"sec-edgar","filing":"0001765581-23-000106","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558123000106/edgardoc.xml","form_type":"4"}},{"id":1860037,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-09T20:15:57.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award made pursuant to Non-Employee Director Compensation Program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date."}],"balance_after":35000,"derivative":{"exercise_price":1.26,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001728117-23-000084","document":"wf-form4_168634174722045.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607737/000172811723000084/wf-form4_168634174722045.xml","form_type":"4"}},{"id":1884296,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2023-05-20T00:45:45.000Z","date":"2023-05-18","kind":"sale","planned":false,"acquired":false,"shares":6000,"price":131.7457,"value":790474.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $131.69 to $131.86. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":35978,"source":{"system":"sec-edgar","filing":"0001765581-23-000042","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558123000042/edgardoc.xml","form_type":"4"}},{"id":1922905,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2023-04-07T21:44:05.000Z","date":"2023-04-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":1807,"price":145.78,"value":263424.46,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":41978,"source":{"system":"sec-edgar","filing":"0001765581-23-000040","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558123000040/edgardoc.xml","form_type":"4"}},{"id":1965452,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2023-03-08T02:14:12.000Z","date":"2023-03-05","kind":"tax_withholding","acquired":false,"shares":1557,"price":142.78,"value":222308.46,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":43785,"source":{"system":"sec-edgar","filing":"0001765581-23-000024","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558123000024/edgardoc.xml","form_type":"4"}},{"id":1965451,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2023-03-08T02:14:12.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":12784,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2023, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years."}],"balance_after":45342,"source":{"system":"sec-edgar","filing":"0001765581-23-000024","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558123000024/edgardoc.xml","form_type":"4"}},{"id":2077522,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2022-12-22T21:53:29.000Z","date":"2022-12-21","kind":"sale","acquired":false,"shares":2635,"price":160,"value":421600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 147 annd 51 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 31, 2022 and November 30, 2022, respectively."}],"balance_after":32558,"source":{"system":"sec-edgar","filing":"0001765581-22-000143","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000143/edgardoc.xml","form_type":"4"}},{"id":2206786,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-15T20:52:20.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award made pursuant to Non-Employee Director Compensation Program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date"}],"balance_after":30000,"derivative":{"exercise_price":7.02,"expiration_date":"2032-06-08","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001728117-22-000067","document":"wf-form4_165791832433011.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607737/000172811722000067/wf-form4_165791832433011.xml","form_type":"4"}},{"id":2301155,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Ordinary Shares","published_at":"2022-04-07T20:17:35.000Z","date":"2022-04-05","kind":"tax_withholding","acquired":false,"shares":1633,"price":162.88,"value":265983.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":34995,"source":{"system":"sec-edgar","filing":"0001765581-22-000038","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000038/edgardoc.xml","form_type":"4"}},{"id":2341463,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Ordinary Shares","published_at":"2022-03-09T22:53:13.000Z","date":"2022-03-05","kind":"disposition_to_issuer","acquired":false,"shares":720,"price":153.96,"value":110851.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":36628,"source":{"system":"sec-edgar","filing":"0001765581-22-000017","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000017/edgardoc.xml","form_type":"4"}},{"id":2341462,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Ordinary Shares","published_at":"2022-03-09T22:53:13.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":11730,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2022, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 147 and 124 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 28 and November 30, 2021, respectively."}],"balance_after":37348,"source":{"system":"sec-edgar","filing":"0001765581-22-000017","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000017/edgardoc.xml","form_type":"4"}},{"id":2673317,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-10T23:52:17.000Z","date":"2021-06-09","kind":"grant","acquired":true,"shares":23500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date."}],"balance_after":23500,"derivative":{"exercise_price":8.97,"expiration_date":"2031-06-08","underlying":"Common Stock","underlying_shares":23500},"source":{"system":"sec-edgar","filing":"0001728117-21-000061","document":"wf-form4_162336911267661.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607737/000172811721000061/wf-form4_162336911267661.xml","form_type":"4"}},{"id":2754108,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Ordinary Shares","published_at":"2021-04-07T21:32:21.000Z","date":"2021-04-05","kind":"tax_withholding","acquired":false,"shares":1515,"price":164.71,"value":249535.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":25347,"source":{"system":"sec-edgar","filing":"0001765581-21-000050","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558121000050/edgardoc.xml","form_type":"4"}},{"id":2825852,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Ordinary Shares","published_at":"2021-03-01T22:51:34.000Z","date":"2021-02-25","kind":"grant","acquired":true,"shares":10115,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2021, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 147 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on November 30, 2020."}],"balance_after":26862,"source":{"system":"sec-edgar","filing":"0001765581-21-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558121000018/edgardoc.xml","form_type":"4"}},{"id":3105040,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-18T21:22:31.000Z","date":"2020-06-17","kind":"grant","acquired":true,"shares":23500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date."}],"balance_after":23500,"derivative":{"exercise_price":12.1,"expiration_date":"2030-06-16","underlying":"Common Stock","underlying_shares":23500},"source":{"system":"sec-edgar","filing":"0001209191-20-037679","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607737/000120919120037679/doc4.xml","form_type":"4"}},{"id":3154173,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-05-11T21:05:00.000Z","date":"2020-05-07","kind":"grant","acquired":true,"shares":37848,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the vesting commencement date of March 16, 2020, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":37848,"derivative":{"exercise_price":109.45,"expiration_date":"2030-05-06","underlying":"Ordinary Shares","underlying_shares":37848},"source":{"system":"sec-edgar","filing":"0001765581-20-000053","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558120000053/edgardoc.xml","form_type":"4"}},{"id":3154172,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2020-05-11T21:05:00.000Z","date":"2020-05-07","kind":"grant","acquired":true,"shares":3652,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the vesting commencement date of March 16, 2020, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":3652,"derivative":{"exercise_price":109.45,"expiration_date":"2030-05-06","underlying":"Ordinary Shares","underlying_shares":3652},"source":{"system":"sec-edgar","filing":"0001765581-20-000053","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558120000053/edgardoc.xml","form_type":"4"}},{"id":3154171,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Ordinary Shares","published_at":"2020-05-11T21:05:00.000Z","date":"2020-05-07","kind":"grant","acquired":true,"shares":16600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of April 5, 2020, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years."}],"balance_after":16600,"source":{"system":"sec-edgar","filing":"0001765581-20-000053","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558120000053/edgardoc.xml","form_type":"4"}},{"id":3493710,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-11T22:38:17.000Z","date":"2019-06-10","kind":"grant","acquired":true,"shares":23500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the\ngrant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board\nof directors of the Issuer through such vesting date."}],"balance_after":23500,"derivative":{"exercise_price":19.54,"expiration_date":"2029-06-09","underlying":"Common Stock","underlying_shares":23500},"source":{"system":"sec-edgar","filing":"0001209191-19-036222","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607737/000120919119036222/doc4.xml","form_type":"4"}},{"id":3754216,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2018-11-21T22:42:19.000Z","date":"2018-11-20","kind":"tax_withholding","acquired":false,"shares":6697,"price":24.79,"value":166018.63,"ownership":{"direct":true},"balance_after":157657,"source":{"system":"sec-edgar","filing":"0001179110-18-013105","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911018013105/edgar.xml","form_type":"4"}},{"id":3835534,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2018-08-22T23:32:41.000Z","date":"2018-08-20","kind":"tax_withholding","acquired":false,"shares":6695,"price":26.95,"value":180430.25,"ownership":{"direct":true},"balance_after":164354,"source":{"system":"sec-edgar","filing":"0001179110-18-010817","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911018010817/edgar.xml","form_type":"4"}},{"id":3836292,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-22T21:38:48.000Z","date":"2018-08-20","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable ratably in equal installments on each monthly anniversary of May 29, 2018 over a one-year period."}],"balance_after":25000,"derivative":{"exercise_price":14.08,"expiration_date":"2028-08-20","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000899243-18-023078","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924318023078/doc4.xml","form_type":"4"}},{"id":3841321,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2018-08-16T23:08:03.000Z","date":"2018-08-15","kind":"sale","acquired":false,"shares":1700,"price":27.4254,"value":46623.18,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices from $27.27 to $27.70. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":171049,"source":{"system":"sec-edgar","filing":"0001179110-18-010637","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911018010637/edgar.xml","form_type":"4"}},{"id":3841320,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2018-08-16T23:08:03.000Z","date":"2018-08-15","kind":"sale","acquired":false,"shares":39839,"price":26.7083,"value":1064031.9637,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices from $26.265 to $27.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":172749,"source":{"system":"sec-edgar","filing":"0001179110-18-010637","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911018010637/edgar.xml","form_type":"4"}},{"id":3841319,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2018-08-16T23:08:03.000Z","date":"2018-08-14","kind":"sale","acquired":false,"shares":2204,"price":27.7386,"value":61135.8744,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices from $27.515 to $28.05. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":212588,"source":{"system":"sec-edgar","filing":"0001179110-18-010637","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911018010637/edgar.xml","form_type":"4"}},{"id":3921625,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2018-05-22T23:01:06.000Z","date":"2018-05-20","kind":"tax_withholding","acquired":false,"shares":21230,"price":24.31,"value":516101.3,"ownership":{"direct":true},"balance_after":214792,"source":{"system":"sec-edgar","filing":"0001179110-18-007370","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911018007370/edgar.xml","form_type":"4"}},{"id":3921624,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2018-05-22T23:01:06.000Z","date":"2018-05-18","kind":"sale","acquired":false,"shares":10000,"price":24.2877,"value":242877.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices from $24.14 to $24.42. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":236022,"source":{"system":"sec-edgar","filing":"0001179110-18-007370","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911018007370/edgar.xml","form_type":"4"}},{"id":3930232,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2018-05-16T23:03:16.000Z","date":"2018-05-14","kind":"grant","acquired":true,"shares":33750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 15, 2016, the reporting person was granted a performance stock award that vests based on the achievement of certain performance conditions over a five-year timeframe from 2016 through December 31, 2020 and continued employment. On May 14, 2018, the performance conditions applicable to 33,750 shares were achieved and such shares will vest on May 20, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 865 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 15, 2018."}],"balance_after":246022,"source":{"system":"sec-edgar","filing":"0001179110-18-006934","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911018006934/edgar.xml","form_type":"4"}},{"id":4008819,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-08T01:38:47.000Z","date":"2018-03-07","kind":"purchase","acquired":true,"shares":9000,"price":15.5335,"value":139801.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average purchase price for the entire number of shares purchased.  The actual purchase prices range from $15.5334 to $15.5399 per share.  Detailed information on the exact number of shares purchased at each purchase price can be obtained from the issuer upon request."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0000899243-18-006756","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924318006756/doc4.xml","form_type":"4"}},{"id":4008818,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-08T01:38:47.000Z","date":"2018-03-06","kind":"purchase","acquired":true,"shares":1000,"price":15.3,"value":15300.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0000899243-18-006756","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924318006756/doc4.xml","form_type":"4"}},{"id":4039495,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2018-02-22T22:38:16.000Z","date":"2018-02-20","kind":"tax_withholding","acquired":false,"shares":5387,"price":29.09,"value":156707.83,"ownership":{"direct":true},"balance_after":211407,"source":{"system":"sec-edgar","filing":"0001179110-18-002606","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911018002606/edgar.xml","form_type":"4"}},{"id":4057124,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2018-02-14T23:19:37.000Z","date":"2018-02-12","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":216794,"source":{"system":"sec-edgar","filing":"0001179110-18-002120","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911018002120/edgar.xml","form_type":"4"}},{"id":4152182,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2017-11-22T21:35:16.000Z","date":"2017-11-20","kind":"tax_withholding","acquired":false,"shares":6753,"price":28.58,"value":193000.74,"ownership":{"direct":true},"balance_after":207794,"source":{"system":"sec-edgar","filing":"0001179110-17-014561","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911017014561/edgar.xml","form_type":"4"}},{"id":4227272,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2017-08-22T22:27:48.000Z","date":"2017-08-20","kind":"tax_withholding","acquired":false,"shares":6752,"price":27.4,"value":185004.8,"ownership":{"direct":true},"balance_after":214547,"source":{"system":"sec-edgar","filing":"0001179110-17-011746","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911017011746/edgar.xml","form_type":"4"}},{"id":4303538,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-26T21:12:47.000Z","date":"2017-05-24","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable ratably in equal installments on each monthly anniversary of May 24, 2017 over one-year period."}],"balance_after":30000,"derivative":{"exercise_price":12.13,"expiration_date":"2027-05-24","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000899243-17-014589","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924317014589/doc4.xml","form_type":"4"}},{"id":4307672,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2017-05-23T23:58:53.000Z","date":"2017-05-20","kind":"tax_withholding","acquired":false,"shares":6753,"price":36.83,"value":248712.99,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,702 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 15, 2017."}],"balance_after":221299,"source":{"system":"sec-edgar","filing":"0001179110-17-007876","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911017007876/edgar.xml","form_type":"4"}},{"id":4430775,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2017-02-23T00:05:34.000Z","date":"2017-02-20","kind":"tax_withholding","acquired":false,"shares":10211,"price":33.78,"value":344927.58,"ownership":{"direct":true},"balance_after":226350,"source":{"system":"sec-edgar","filing":"0001179110-17-002988","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911017002988/edgar.xml","form_type":"4"}},{"id":4461141,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2017-02-09T00:05:49.000Z","date":"2017-02-06","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":236561,"source":{"system":"sec-edgar","filing":"0001179110-17-001997","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911017001997/edgar.xml","form_type":"4"}},{"id":4544545,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2016-11-22T23:01:36.000Z","date":"2016-11-20","kind":"tax_withholding","acquired":false,"shares":4628,"price":31.96,"value":147910.88,"ownership":{"direct":true},"balance_after":227561,"source":{"system":"sec-edgar","filing":"0001179110-16-031975","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911016031975/edgar.xml","form_type":"4"}}]}